Resultados de procura - Seth Seegobin

  • Mostrando 1 - 10 Resultados de 10
Limitar resultados
  1. 1
    ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial

    ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial por Seth Seegobin, Margaret HY, Chanaka Dahanayake, Andrew P. Cope, David L. Scott, Cathryn M. Lewis, Ian C. Scott

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer

    Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer por Hyman B. Muss, Javier Cortés, Linda T. Vahdat, Fátima Cardoso, Chris Twelves, J. Wanders, Corina E. Dutcus, Jay Yang, Seth Seegobin, Joyce O’Shaughnessy

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa

    Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa por Sophie Glatt, Gregor B. E. Jemec, Seth Forman, Christopher Sayed, George Schmieder, Jamie Weisman, Robert Rolleri, Seth Seegobin, Dominique Baeten, Lucian Ionescu, Christos C. Zouboulis, Stevan Shaw

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults

    Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab)... por Pablo Forte-Soto, Muna Albayaty, Dennis Brooks, Rosalinda H. Arends, John Tillinghast, Anastasia A. Aksyuk, Jérôme Bouquet, Cecil Chen, Asfiha Gebre, Robert Kubiak, Venkatesh Pilla Reddy, Seth Seegobin, Katie Streicher, Alison Templeton, Mark T. Esser

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Predicting the Risk of Rheumatoid Arthritis and Its Age of Onset through Modelling Genetic Risk Variants with Smoking

    Predicting the Risk of Rheumatoid Arthritis and Its Age of Onset through Modelling Genetic Risk Variants with Smoking por Ian C. Scott, Seth Seegobin, Sophia Steer, Rachael Tan, Paola Forabosco, Anne Hinks, Stephen Eyre, Ann W. Morgan, Anthony G. Wilson, Lynne J. Hocking, P Wordsworth, Anne Barton, Jane Worthington, Andrew P. Cope, Cathryn M. Lewis

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

    Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-cont... por Hugh Montgomery, Richard Hobbs, Francisco Padilla, Douglas Arbetter, Alison Templeton, Seth Seegobin, Kenneth Kim, Jesus Abraham Simón Campos, Rosalinda H. Arends, Bryan H Brodek, Dennis Brooks, Pedro Garbes, Julieta Jimenez, Gavin Koh, Kelly Padilla, Katie Streicher, Rolando M. Viani, Vijay Alagappan, Menelas N. Pangalos, Mark T. Esser

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019

    AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019 por Myron J. Levin, Andrew Ustianowski, S. Thomas, Alison Templeton, Yuan Yuan, Seth Seegobin, Catherine Houlihan, Ibrahim Menendez-Perez, Simon Pollett, Rosalinda H. Arends, Rohini Beavon, Kanika Dey, Pedro Garbes, Elizabeth J. Kelly, Gavin Koh, Stefan Ivanov, Karen A. Near, Audrey Sharbaugh, Katie Streicher, Menelas N. Pangalos, Mark T. Esser

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19

    Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 por Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, Odile Launay, Miles Avila, Alison Templeton, Yuan Yuan, Seth Seegobin, Adam Ellery, Dennis J. Levinson, Philip Ambery, Rosalinda H. Arends, Rohini Beavon, Kanika Dey, Pedro Garbes, Elizabeth J. Kelly, Gavin Koh, Karen A. Near, Kelly Padilla, Konstantina Psachoulia, Audrey Sharbaugh, Katie Streicher, Menelas N. Pangalos, Mark T. Esser

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study

    Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South A... por Sue Ann Costa Clemens, Brett Jepson, Qasim Bhorat, Abdullahi Ahmad, Tauseefullah Akhund, Parvinder K. Aley, Himanshu Bansal, Sagida Bibi, Elizabeth J. Kelly, Mark Khan, Teresa Lambe, Johan Lombaard, Samuel A. Matthews, Eveline Pı́polo Milan, Urban Olsson, Maheshi Ramasamy, Maria Sanali Moura de Oliveira Paiva, Seth Seegobin, Kathryn Shoemaker, Ameena Szylak, Tonya Villafana, Andrew J. Pollard, Justin A Green

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02

    Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02 por Christos Tziotzios, Christos Petridis, Nick Dand, Chrysanthi Ainali, Jake Saklatvala, Venu Pullabhatla, Alexandros Onoufriadis, Rashida Pramanik, David Baudry, Sang Hyuck Lee, Kristie Wood, Lu Liu, Seth Seegobin, Gregory Michelotti, Su M. Lwin, Evangelos Christou, Charles Curtis, Emanuele de Rinaldis, Alka Saxena, Simon Holmes, Matthew Harries, Ioulios Palamaras, Fiona Cunningham, G. Parkins, Manjit Kaur, Paul Farrant, A.J.G. McDonagh, Andrew G. Messenger, Jennifer Jones, Victoria Jolliffe, Iaisha Ali, Michael R. Ardern‐Jones, Charles D. Mitchell, Nigel Burrows, Ravinder Atkar, Cedric C. Banfield, A.B. Alexandroff, Caroline Champagne, Hywel Cooper, Sergio Vañó‐Galván, A.M. Molina‐Ruiz, Nerea Ormaechea Perez, Girish K. Patel, A. E. Macbeth, Melanie C. Page, Alyson Bryden, Megan Mowbray, Shyamal Wahie, Keith Armstrong, Nicola Cooke, Mark Goodfield, Irene Man, David de Berker, Giles Dunnill, Anita Takwale, Archana S. Rao, Tee-Wei Siah, Rodney Sinclair, Martin Wade, Ncoza C. Dlova, Jane Setterfield, Fiona Lewis, Kapil Bhargava, Niall Kirkpatrick, Xavier Estivill, Catherine M. Stefanato, Carsten Flohr, Timothy D. Spector, Fiona M. Watt, Catherine Smith, Juliet N. Barker, David A. Fenton, Michael A. Simpson, John A. McGrath

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: